Filing Details

Accession Number:
0001209191-21-022613
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-23 17:33:48
Reporting Period:
2021-03-19
Accepted Time:
2021-03-23 17:33:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000694 Novavax Inc NVAX Biological Products, (No Disgnostic Substances) (2836) 222816046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1051997 Jr A Michael Mcmanus C/O Novavax, Inc.
21 Firstfield Road
Gaithersburg MD 20878
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-19 1,000 $221.40 8,951 No 4 S Direct
Common Stock Disposition 2021-03-19 3,000 $220.57 5,951 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct